1 Henson DE,DittusC,Younes M,et al.Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States,1973-2000:increase in the signet ring cell type[J].Arch Pathol Lab Med,2004,128(7):765-770. 2 Kwon KJ,Shim KN,Song EM,et al.Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach[J].Gastric Cancer,2014,17(1):43-53. 3 Shim JH,Song KY,Kim HH,et al.Signet ring cell histology is not an independent predictor of poor prognosis after curative resection for gastric cancer[J].Medicine,2014,93(27):136-139. 4 Kim JP,Kim SC,Yang HK.Prognostic significance of signet ring cell carcinoma of the stomach[J].Surg Oncol,1994,3(4):221-227. 5 Yendamuri S,Huang M,Malhotra U,et al.Prognostic implications of signet ring cell histology in esophageal adenocarcinoma[J].Cancer,2013,119(17):3156-3161. 6 Zu H,Wang H,Li C,et al.Clinicopathologic characteristics and prognostic value of various histological types in advanced gastric cancer[J].Int J Exp Pathol,2014,7(9):5692-5700. 7 Lee HH,Song KY,Park CH,et al.Undifferentiated-type gastric adenocarcinoma:prognostic impact of three histological types[J].World J Surg Oncol,2012,10(1):254. 8 Pernot S,VoronT,Perkins G,et al.Signet-ring cell carcinoma of the stomach:Impact on prognosis and specific therapeutic challenge[J].World J Gastroenterol,2015,21(40):11428-11438. 9 Kim BS,Oh ST,Yook JH,et al.Signet ring cell type and other histologic types:differing clinical course and prognosis in T1 gastric cancer[J].Surgery,2014,155(6):1030-1035. 10 Shimizu H,Ichikawa D,Komatsu S,et al.The decision criterion of histological mixed type in “T1/T2” gastric carcinoma—comparison between TNM classification and Japanese Classification of Gastric Cancer[J].J Surg Oncol,2012,105(8):800-804. 11 Zhang M,Zhu G,Zhang H,et al.Clinicopathologic features of gastric carcinoma with signet ring cell histology[J].J Gastrointest Surg,2010,14(4):601-606. 12 Takehana T,Kunitomo K,Suzuki S,et al.Expression of epidermal growth factor receptor in gastric carcinomas[J].Clin Gastroenterol Hepatol,2003,1(6):438-445. 13 Red Brewer M,Yun,CH,Lai D,et al.Mechanism for activation of mutated epidermal growth factor receptors in lung cancer[J].Proc Natl Acad Sci USA,2013,110(38):3595-3604. 14 Zha Y,Cun Y,Zhang Q,et al.Prognostic value of expression of Kit67,p53,TopoIIa and GSTP1 for curatively resected advanced gastric cancer patients receiving adjuvant paclitaxel plus capecitabine chemotherapy[J].Hepatogastroenterology,2012,59(117):1327-1332. 15 Morgan C,Jenkins GJ,Ashton T,et al.Detection of p53 mutations in precancerous gastric tissue[J].Br J Cancer,2003,89(7):1314-1319. 16 Lee CM,Cho JM,Jang YJ,et al.Should lymph node micrometastasis be considered in node staging for gastric cancer ?:the significance of lymph node micrometastasis in gastric cancer[J].Ann Surg Oncol,2015,22(3):765-771. |